Origins of neoantigens for the major histocompatibility complex class I pathway

Ewa Sroka , Rodrigo Prado Martins , Chrysoula Daskalogianni , Sebastien Apcher , Robin Fahraeus

Abstract

n/a
Publication typeOriginal work published as abstract
Author Ewa Sroka (IFB / IB / LRV)
Ewa Sroka,,
- Laboratory of Recombinant Vaccines
, Rodrigo Prado Martins (ICCVS)
Rodrigo Prado Martins,,
- International Centre for Cancer Vaccine Science
, Chrysoula Daskalogianni (ICCVS)
Chrysoula Daskalogianni,,
- International Centre for Cancer Vaccine Science
, Sebastien Apcher (ICCVS)
Sebastien Apcher,,
- International Centre for Cancer Vaccine Science
, Robin Fahraeus (ICCVS)
Robin Fahraeus,,
- International Centre for Cancer Vaccine Science
Journal seriesCancer immunology research, ISSN 2326-6066, e-ISSN 2326-6074, (0 pkt)
Issue year2019
Vol7
No2 Suppl
Pages1-1
Publication size in sheets0.3
Article numberB187
Conference4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference "Translating Science into Survival", 30-09-2018 - 03-10-2018, New York, Stany Zjednoczone
ASJC Classification1306 Cancer Research; 2403 Immunology
DOIDOI:10.1158/2326-6074.CRICIMTEATIAACR18-B187
Languageen angielski
Not used for evaluationyes
Score (nominal)0
Score sourcejournalList
Publication indicators Scopus SNIP (Source Normalised Impact per Paper): 2018 = 1.538; WoS Impact Factor: 2018 = 8.619 (2) - 2018=9.738 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back
Confirmation
Are you sure?